My Account
Follow us on:
Powered By
See the top gainers, losers, invest and get updated what's happening in the crypto market
Invest Now
This functionality will provide users with ease of access navigation and enable create a new revenue line by generating leads of potential customers for brokers in a more integrated manner.
Nifty 50
24741.00
+6.70 (+0.03%)
Sensex
80710.76
-7.25 (-0.01%)
BSE: 524578 | NSE: | Series: NA | ISIN: INE840C01017 | SECTOR: PharmaceuticalsPharmaceuticals
BSE Live
Prev. Close
5.80
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
NSE Live
01.01.1970
22.07.2021
Gland Pharma’s new product play for FY22 holds a lot of promise
15.11.2017
Hold Indoco Remedies; target of Rs 250: ICICI Direct
05.10.2017
Buy Natco Pharma; target of Rs 1065: ICICI Direct
18.07.2017
Cipla Q1 PAT may dip 46.52% YoY to Rs 199.6 cr: KR Choksey
28.02.2017
Sanofi India Q4 net declines 58% to Rs 50.5 cr
27.02.2017
Merck Dec-qtr net up 25% at Rs 18 cr
14.02.2017
Claris Lifesciences net profit up 233 pc at Rs 35 cr in Q3
Sun Pharma Q3 profit dragged by slowdown in US & India sales
13.02.2017
Sun Pharma Q3 profit seen up 27%; US & India biz may grow 10%
09.02.2017
Aurobindo Q3 profit seen up 14%, revenue may grow 10% on US biz
Lupin Q3 profit seen up 15% to Rs 609cr, US biz may lift revenue
15.02.2017
Ranbaxy deal to kick in, Halol overhang on Sun Pharma:Brokerages
06.02.2017
Good Q3 but Dr Reddy's still far from sustainable growth: Expert
10.11.2016
Sun Pharma Q2 show healthy but margins unsustainable: Nangra
09.11.2016
Low earnings for Lupin to continue for next 2 qtrs: IIFL